ATE243024T1 - Zusammensetzung zur kontrollierten freisetzung - Google Patents

Zusammensetzung zur kontrollierten freisetzung

Info

Publication number
ATE243024T1
ATE243024T1 AT98900793T AT98900793T ATE243024T1 AT E243024 T1 ATE243024 T1 AT E243024T1 AT 98900793 T AT98900793 T AT 98900793T AT 98900793 T AT98900793 T AT 98900793T AT E243024 T1 ATE243024 T1 AT E243024T1
Authority
AT
Austria
Prior art keywords
controlled release
composition
release composition
active material
biologically active
Prior art date
Application number
AT98900793T
Other languages
German (de)
English (en)
Inventor
Kare Larsson
Helena Ljusberg-Wahren
Niels Krog
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Application granted granted Critical
Publication of ATE243024T1 publication Critical patent/ATE243024T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98900793T 1997-01-13 1998-01-08 Zusammensetzung zur kontrollierten freisetzung ATE243024T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
PCT/SE1998/000009 WO1998030206A1 (en) 1997-01-13 1998-01-08 Controlled release composition

Publications (1)

Publication Number Publication Date
ATE243024T1 true ATE243024T1 (de) 2003-07-15

Family

ID=20405393

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98900793T ATE243024T1 (de) 1997-01-13 1998-01-08 Zusammensetzung zur kontrollierten freisetzung

Country Status (9)

Country Link
US (1) US6660278B1 (enExample)
EP (1) EP0954287B1 (enExample)
JP (1) JP2001508773A (enExample)
AT (1) ATE243024T1 (enExample)
AU (1) AU5583298A (enExample)
CA (1) CA2277377C (enExample)
DE (1) DE69815659T2 (enExample)
SE (1) SE511313C2 (enExample)
WO (1) WO1998030206A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US6887487B2 (en) * 2001-10-19 2005-05-03 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
US20050049210A1 (en) * 2003-08-27 2005-03-03 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
SG173326A1 (en) * 2004-06-04 2011-08-29 Camurus Ab Liquid depot formulations
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036983A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Pre-dried drug delivery coating for use with a stent
US8124127B2 (en) 2005-10-15 2012-02-28 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
WO2006036964A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Barrier layer
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US8288348B2 (en) * 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US8574627B2 (en) 2006-11-06 2013-11-05 Atrium Medical Corporation Coated surgical mesh
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
EP2393472B1 (en) 2008-12-05 2019-06-05 NanoMed Holdings Pty Ltd Amphiphile prodrugs
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2011050388A1 (en) * 2009-10-30 2011-05-05 Monash University Liquid crystal composition and method of use
KR101663551B1 (ko) * 2010-05-18 2016-10-07 후지필름 가부시키가이샤 카로티노이드 함유 조성물 및 그 제조 방법
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
LT2877155T (lt) 2012-07-26 2021-02-25 Camurus Ab Opioidų vaisto formos
PL2877155T3 (pl) 2012-07-26 2021-05-17 Camurus Ab Formulacje opioidowe
MX391097B (es) 2017-11-27 2025-03-21 Umecrine Cognition Ab FORMULACIÓN FARMACÉUTICA DE 3A-ETINIL-3ß-HIDROXIANDROSTAN-17-ONA OXIMA.
CN113166189A (zh) 2018-04-26 2021-07-23 纳米医学控股有限公司 吉西他滨两亲性前体药物
SG11202107877WA (en) 2018-06-21 2021-08-30 NanoMed Holdings Pty Ltd Platinum-based amphiphile prodrugs
US20240083107A1 (en) * 2021-01-29 2024-03-14 Ioi Oleo Gmbh Polyglycerol fatty acid ester-containing composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5321393B2 (enExample) * 1974-10-19 1978-07-03
US5264460A (en) * 1988-05-30 1993-11-23 Deutsche Solvay-Werke Gmbh Process for preparing nonionic surfactants
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
DE69229779T2 (de) 1991-04-19 1999-12-23 Lds Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US6013269A (en) * 1994-10-12 2000-01-11 The Procter & Gamble Company Cosmetic make-up compositions
SE504582C2 (sv) 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky

Also Published As

Publication number Publication date
AU5583298A (en) 1998-08-03
CA2277377A1 (en) 1998-07-16
EP0954287B1 (en) 2003-06-18
US6660278B1 (en) 2003-12-09
EP0954287A1 (en) 1999-11-10
SE9700061L (sv) 1998-07-14
CA2277377C (en) 2007-12-18
DE69815659T2 (de) 2004-04-29
DE69815659D1 (de) 2003-07-24
SE9700061D0 (sv) 1997-01-13
SE511313C2 (sv) 1999-09-06
JP2001508773A (ja) 2001-07-03
WO1998030206A1 (en) 1998-07-16

Similar Documents

Publication Publication Date Title
DE69815659D1 (de) Zusammensetzung zur kontrollierten freisetzung
ES2153355T3 (es) Procedimiento para la preparacion de microesferas que contienen compuestos biologicamente activos.
DE69836491D1 (de) Fibrinmikrokugeln und deren verwendungen
IL106248A (en) Adhesive compositions and method of bonding biological tissue to a substance
PT774962E (pt) Utilizacao de dha como uma composicao farmaceutica
HUP0000937A2 (hu) Új zsírsav-származékok
ES2196502T3 (es) Composicion y metodo para inhibir el desarrollo de microorganismos que incluye hipobromito sodico estabilizado e isotiazolonas.
DK0549774T3 (da) Anvendelse af porøst calciumcarbonat som bærermateriale for in vitro cellekulturer
AU561811B2 (en) Organic amide compounds derived from nitrogenous lipids
DE69531864D1 (de) Indolizin spal2 inhibitoren
EP0681846A3 (en) Cell culture products.
DE59308413D1 (de) Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung
AU1911999A (en) Methods and compositions for treating diabetes
CA2263557A1 (en) Implant consisting of a carrier material containing medical substances and method to produce such an implant
AU1576092A (en) Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material
JPS57117868A (en) Method of combining biological active substance to carrier containing hydroxyl group
DE59708441D1 (de) Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten
YU47192A (sh) Transdermalni tretirajući sistem sa supstancom kao nosačem za potpomaganje transdermalne penetracije i postupak za njegovo dobijanje
AU4836497A (en) Enhancing keratinocyte migration and proliferation
GB2324528A (en) Cytostatic hydroxamic acid derivatives
CO4600643A1 (es) Procedimiento de acondicionamiento de tejidos de vegetales cultivados en vitro y dispositivo para dicho acondicionamiento
ES2057382T3 (es) Composicion que contenga 2-tiocianometilotiobenzotiazol.
NZ508073A (en) Biologically active composition
ES2127278T3 (es) Preparados de acidos 2-aril-propionicos y procedimiento para su produccion.
AU2747695A (en) Microencapsulated labelling technique

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties